Advertisement

License Photo

CONGRESS LOOKS INTO VIOXX AND FDA
Dr. David J. Graham, MPH, Associate Director for Science, Office of Drug Safety, Center for Drug Evaluation and Research, U.S. Department of Health and Human Services, Food and Drug Administration testifies before the Senate Finance Committee hearing on FDA, Merck, and Vioxx on November 18, 2004 in Washington. Graham said that Vioxx was a definite threat and that there are at least five drugs on the market he would take off...(UPI Photo/Michael Kleinfeld)

Please fill out form for pricing information for the photo below.
CONGRESS LOOKS INTO VIOXX AND FDA
Please enter the numbers you see to the right.